Word: shrank
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...midsummer, even before the Republicans gathered in New Orleans, these attacks had effect. Dukakis' negatives began to rise, and his lead over Bush shrank. The Democrat had allowed his hold on voters to remain so frail that even trivial events damaged him. His standing slipped in early August, for instance, after Reagan called him an "invalid" while Republicans floated a rumor that Dukakis had once sought psychological counseling. Reagan retracted his remark, and the gossip proved unfounded, but it left a scar. Bush planted what might be a more durable brand; in TIME's poll, 40% of likely voters agreed...
...Entertainment, conceded last week that if the strike lasts into June, fall shows may be delayed until November. The networks can ill afford to give viewers more reason to switch to cable channels and videocassettes. Last week the Nielsen ratings showed that the networks' share of the viewing audience shrank 9% during the past season...
...bringing down the trade deficit has been painfully slow. After two months of sharp improvements in the trade gap, the Government reported last week that the deficit had edged up again, from $12.2 billion in December to $12.4 billion in January. On the bright side, the deficit with Japan shrank 17.5%. But the imbalance with other Asian countries, including South Korea and Taiwan, ballooned...
...registered voters are asked whether they consider either Bush or Dole "too quick- tempered to be President," 43% say neither, 15% name Bush and 12% Dole. Though Bush had just received a snowstorm of favorable publicity for winning New Hampshire, his lead over Dole among likely Republican voters shrank from 25 points in January to 18 points last week. Dole, however, still faces serious obstacles. Bush's advantage over Dole is greatest in the South (53% vs. 23%), where the next major round will be fought...
...drug that could prove more potent and longer lasting than Mevacor; an anti-ulcer medication that has shown a high degree of effectiveness; MK- 538, a drug that holds promise of aiding diabetes sufferers. Merck will soon launch large-scale clinical trials for MK-906, which in preliminary tests shrank swollen prostate glands without bad side effects, alleviating a problem that vexes millions of men over 40. Other teams are studying cures for cataracts, arthritis, cancer and AIDS. But so are Merck's rivals. London-based Burroughs Wellcome last week won, as expected, the U.S. patent...